Disclaimer :

The Competition DG makes the information provided by the notifying parties in section 1.2 of Form CO available to the public in order to increase transparency. This information has been prepared by the notifying parties under their sole responsibility, and its content in no way prejudges the view the Commission may take of the planned operation. Nor can the Commission be held responsible for any incorrect or misleading information contained therein.

SECTION 1.2

Description of the concentration

1.On 2 August 2013, the Commission received the notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) 139/2004 ("EUMR") by which M&G Investment Management Limited ("M&G") whose ultimate parent is Prudential plc will acquire, within the meaning of Article 3(1)(b) of the EUMR, sole control over the Alliance Medical group of companies through an indirect acquisition of a majority interest by funds managed by M&G in the framework of a restructuring process involving a debt-to-equity swap.

The business activities of the undertakings concerned are:

-• Alliance Medical: primarily provision of outsourced diagnostic imaging services for hospitals and doctors’ surgeries, and the manufacture and distribution of radiopharmaceuticals and tracers used for diagnostic imaging.

-• M&G: M&G is a wholly-owned subsidiary of Prudential plc, an international insurance group headquartered in London, United Kingdom, and is the investment management division of Prudential plc in Europe.